Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 63   

Articles published

PFE 33.62 0.00 (0.00%)
price chart
Report: Pfizer voluntarily recalled 650000 bottles of Advil Liqui-Gels
Advil.jpg AP/FILEPfizer Inc. voluntarily recalled more than 650,000 bottles of Advil Liqui-Gels, due to an unusually strong odor.
Pfizer announces results from Lyrica clinical studies on fibromyalgia
Pfizer Inc. (NYSE: PFE) announced the results of studies on Lyrica� (pregabalin) capsules CV presented at the American Pain Society Annual Meeting in Honolulu.
Pfizer recalls 650000 bottles of Advil Liqui-Gels
Pfizer Inc. has recalled more than 650,000 bottles of Advil pain-relief medicine due to the potential for a strong odor in the product.
PPD names new CEO
Pfizer Inc. executive David Simmons has been named chairman and CEO of PPD, the Wilmington-based company said Wednesday. Simmons is the first CEO named by the clinical research company since it was taken private in December by The Carlyle ...
PPD names Pfizer executive David Simmons its new CEO  MedCity News
Mylan Denied Invalidity In Cancer Drug IP Battle
Law360, New York (May 2, 2012, 5:42 PM EDT) -- A Delaware federal judge Tuesday found in favor of Genentech Inc., Pfizer Inc. and Astellas Pharma Inc. unit OSI Pharmaceuticals Inc. in their patent infringement suit against Mylan Pharmaceuticals Inc ...
Dow Chemical taking Pfizer space
COLLEGEVILLE —Dow Chemical Co. has finalized a long-term lease on 800,000 square feet of space at Pfizer Inc.'s campus here in what is one of the largest lease deals to be struck in the suburban office market.
Pfizer Takes on Genzyme With New Gaucher Drug
Last night, just hours after New York drug giant Pfizer (NYSE: PFE) reported first-quarter profits that suffered from generic competition on its blockbuster cholesterol drug atorvastatin (Lipitor), the company announced that the FDA approved its new ...
Protalix's FDA Approval And 1-Year Price Target  Seeking Alpha
Ruga Corporation Expands Management Team to Advance Its Adapative Response ...
Dr. O'Connor spent a decade at the Agouron/Pfizer-La Jolla site in California eventually becoming Head of Global Oncology Research at Pfizer, Inc. During his tenure, Dr. O'Connor's cancer group discovered and brought into development the now approved ...
Pregabalin Treats Neuropathic Pain in Spinal Cord Injury
... to fill a treatment gap for SCI patients, according to investigators Luis Sanin, MD, Clinical Sciences, Medicines Development Group and Bruce Parsons, MD, PhD, senior medical director, US Medical Affairs, Primary Care Business Unit, both at Pfizer Inc.
Antibiotic linked with rare but deadly heart risk
The National Heart, Lung and Blood Institute helped pay for the research. Zithromax, marketed by Pfizer Inc., has been available in the United States for two decades.
Zithromax antibiotics tied to rare heart risks  CBS News